MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MP-23-0008669
Nikem Drugs Private Limited
Nikem Drugs Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.46 Cr
▼ 53% YoY
Net profit · FY 2025
₹79,355
Net margin 0.2%
EBITDA · FY 2025
₹33.85 Lakh
EBITDA margin 7.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹3.16 Cr
Satisfied ₹49.5 Lakh
Company age
24 yrs
Est. 2002
Employees · EPFO
7
Provident fund records
About Nikem Drugs Private Limited
Data last updated:
Nikem Drugs Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 December 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2002PTC015469. Its GSTIN is 23AABCN8199H1Z6 (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rajesh Gangwani and Geeta Gangwani.
Its last annual general meeting (AGM) was held on 30 November 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 245 Sector – F Industrial Area Sanwer Road, Indore, Madhya Pradesh, India – 452010.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.46 Cr, a decline of 53% compared to the previous year. For the same year it recorded a net profit of ₹79,355 (net margin 0.2%) and EBITDA of ₹33.85 Lakh (EBITDA margin 7.6%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 7% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.16 Cr and satisfied charges of ₹49.5 Lakh on record. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 1 case is pending.
Nikem Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0008669). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232MP2002PTC015469
Registration Number 015469
Incorporation Date 30 December 2002
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0008669
Key People
Rajesh Gangwani Director Geeta Gangwani Director Recognitions & Rankings of Nikem Drugs
Contact details
Nikem Drugs Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address245 Sector – F Industrial Area Sanwer Road, Indore, Madhya Pradesh, India – 452010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nikem Drugs Private Limited, buy the company report.
Comprehensive company report
Nikem Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nikem Drugs is manufacturing. In detail, this covers plastic products, non-metallic mineral products, rubber products, fabricated metal products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C8 | Plastic products, non-metallic mineral products, rubber products, fabricated metal products |
To see the full business activity and turnover split of Nikem Drugs Private Limited, buy the company report.
Financials of Nikem Drugs Private Limited
FY 2024 filings availableNikem Drugs Private Limited reported revenue of ₹4.46 Cr (down 53% YoY) for FY 2025.
Revenue · FY 2025
₹4.46 Cr ▼ 53%
Net profit · FY 2025
₹79,355 margin 0.2%
EBITDA · FY 2025
₹33.85 Lakh margin 7.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 53%
3 years · compounded
▼ 22%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 5%
5 years · compounded
▲ 7%
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 53% fall in the latest year. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.85 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹79,355 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nikem Drugs Private Limited, buy the company report.
Board of directors of Nikem Drugs Private Limited
Nikem Drugs has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Gangwani | Director | 30 Dec 2002 | 23 Years 10 Months | Current |
| Geeta Gangwani | Director | 30 Dec 2002 | 23 Years 10 Months | Current |
Auditor
Nikem Drugs Private Limited is audited by M/S SANJAY SODANI & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/S SANJAY SODANI & CO | FY 2024 | 004361C |
Shareholding
The shareholding of Nikem Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nikem Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.16 Cr
Satisfied charges
₹49.5 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Aug 2024 | 101006952 | Hdfc Bank Limited | ₹6.5 Lakh | Open | |
| 26 Sep 2017 | 100142064 | Hdfc Bank Limited | ₹1.6 Cr | Open | |
| 11 Sep 2017 | 100128171 | Hdfc Bank Limited | ₹1.35 Cr | Open | |
| 10 Sep 2003 | 90205977 | State Bank of Saurashtra | ₹14.5 Lakh | Open | |
| 03 Apr 2006 | 10056957 | Union Bank of India | ₹49.5 Lakh | Satisfied |
To see the full charge records of Nikem Drugs Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Nikem Drugs Private Limited has 4 court cases on record: 1 filed by Nikem Drugs, 3 filed against it. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
1
Filed against the company
3
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 1 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ananthapur, Andhra Pradesh | Criminal case | Filed against the company by State Rep by Drug Inspector , Hindupur. | Pending |
| District court, Ananthapur, Andhra Pradesh | Criminal case | Filed against the company by State Rep by Drug Inspector , Hindupur. | Disposed |
| District court, Kadapa, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, KALABURAGI, Karnataka | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Nikem Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nikem Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nikem Drugs Private Limited has a workforce of 7 employees on its EPFO records as of Mar 05, 2025, across 1 active EPFO establishment.
Employee count
7
Active EPFO establishments
1
Employee growth
16.67%
GST
Nikem Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCN8199H1Z6 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nikem Drugs Private Limited, buy the company report.
Recent activity
Nikem Drugs Private Limited has 2 board changes on record since 2002: 2 appointments. The latest: Geeta Gangwani was appointed as Director on 30 Dec 2002.
AGM
Nikem Drugs Private Limited last Annual general meeting of members was held on 30 Nov 2024 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 6.50 Lakh with Charge ID 101006952 was registered on 23 Aug 2024.
Filing
Nikem Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Charges
A charge with Hdfc Bank Limited of Rs. 160.00 Lakh registered on 26 Sep 2017 with Charge ID 100142064 was modified on 05 Nov 2022.
Charges
A charge with Hdfc Bank Limited of Rs. 135.00 Lakh registered on 11 Sep 2017 with Charge ID 100128171 was modified on 09 Feb 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 160.00 Lakh with Charge ID 100142064 was registered on 26 Sep 2017.
Charges
A charge registered on 03 Apr 2006 via Charge ID 10056957 with Union Bank Of India was fully satisfied on 21 Sep 2017.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 135.00 Lakh with Charge ID 100128171 was registered on 11 Sep 2017.
Charges
A charge with Union Bank Of India amounted to Rs. 49.50 Lakh with Charge ID 10056957 was registered on 03 Apr 2006.
Charges
A charge with State Bank Of Saurashtra amounted to Rs. 14.50 Lakh with Charge ID 90205977 was registered on 10 Sep 2003.
Appointed
Geeta Gangwani was appointed as Director.
Appointed
Rajesh Gangwani was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Nikem Drugs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 December 2002 (24+ years old) and is registered under CIN U24232MP2002PTC015469.
Nikem Drugs has 2 current directors:
- Rajesh Gangwani - Director
- Geeta Gangwani - Director
The latest financial statements of Nikem Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 November 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Nikem Drugs is 23AABCN8199H1Z6, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Nikem Drugs is U24232MP2002PTC015469. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nikem Drugs has 4 court cases on record: 1 filed by the company and 3 filed against it. 1 is pending.
Nikem Drugs was incorporated on 30 December 2002, making it 24+ years old. It is registered with the Registrar of Companies, Gwalior.
Geeta Gangwani was appointed as Director on 30 Dec 2002. Rajesh Gangwani was appointed as Director on 30 Dec 2002.
Yes, Nikem Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0008669).
The registered office of Nikem Drugs is at 245 Sector – F Industrial Area Sanwer Road, Indore, Madhya Pradesh, India – 452010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages